Filings

6 documents · 73 matches

1. VERA Vera Therapeutics, Inc. 10-Q 2026-11-05

   Item 1A. Risk Factors.

   tariffs may result in increased product manufacturing costs and/or research and development expenses, including with respect to increased costs associated
   12 matches in this document Show context Copy citation

2. VERA Vera Therapeutics, Inc. 10-Q 2026-08-10

   Item 1A. Risk Factors.

   tariffs may result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients
   12 matches in this document Show context Copy citation

3. VERA Vera Therapeutics, Inc. 10-K 2026-02-26

   Item 1A. Risk Factors.

   tariffs may result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients
   13 matches in this document Show context Copy citation

4. VERA Vera Therapeutics, Inc. 10-Q 2025-11-05

   Item 1A. Risk Factors.

   tariffs may result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients
   12 matches in this document Show context Copy citation

5. VERA Vera Therapeutics, Inc. 10-Q 2025-08-05

   Item 1A. Risk Factors.

   tariffs may result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients
   11 matches in this document Show context Copy citation

6. VERA Vera Therapeutics, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   tariffs affecting a wide range of products and jurisdictions and has indicated an intention to continue developing new trade policies
   13 matches in this document Show context Copy citation